Sidgwick, G.P.; Weston, R.; Mahmoud, A.M.; Schiro, A.; Serracino-Inglott, F.; Tandel, S.M.; Skeoch, S.; Bruce, I.N.; Jones, A.M.; Alexander, M.Y.;
et al. Novel Glycomimetics Protect against Glycated Low-Density Lipoprotein-Induced Vascular Calcification In Vitro via Attenuation of the RAGE/ERK/CREB Pathway. Cells 2024, 13, 312.
https://doi.org/10.3390/cells13040312
AMA Style
Sidgwick GP, Weston R, Mahmoud AM, Schiro A, Serracino-Inglott F, Tandel SM, Skeoch S, Bruce IN, Jones AM, Alexander MY,
et al. Novel Glycomimetics Protect against Glycated Low-Density Lipoprotein-Induced Vascular Calcification In Vitro via Attenuation of the RAGE/ERK/CREB Pathway. Cells. 2024; 13(4):312.
https://doi.org/10.3390/cells13040312
Chicago/Turabian Style
Sidgwick, Gary P., Ria Weston, Ayman M. Mahmoud, Andrew Schiro, Ferdinand Serracino-Inglott, Shikha M. Tandel, Sarah Skeoch, Ian N. Bruce, Alan M. Jones, M. Yvonne Alexander,
and et al. 2024. "Novel Glycomimetics Protect against Glycated Low-Density Lipoprotein-Induced Vascular Calcification In Vitro via Attenuation of the RAGE/ERK/CREB Pathway" Cells 13, no. 4: 312.
https://doi.org/10.3390/cells13040312
APA Style
Sidgwick, G. P., Weston, R., Mahmoud, A. M., Schiro, A., Serracino-Inglott, F., Tandel, S. M., Skeoch, S., Bruce, I. N., Jones, A. M., Alexander, M. Y., & Wilkinson, F. L.
(2024). Novel Glycomimetics Protect against Glycated Low-Density Lipoprotein-Induced Vascular Calcification In Vitro via Attenuation of the RAGE/ERK/CREB Pathway. Cells, 13(4), 312.
https://doi.org/10.3390/cells13040312
